Open Orphan sees positive trial on mosquito-borne disesases
Company is developing a vaccine to guard against diseases such as malaria and zika
Mosquitos carry several diseases such as malaria, dengue fever, and zika.
A trial by Dublin-listed pharmaceutical services company Open Orphan has ascertained that a vaccine it is developing for mosquito-borne diseases such as zika and malaria is “safe and induces a strong immune response in healthy volunteers”.
Open Orphan, a European-focused, rare and orphan drug consulting services platform, informed the Irish stock market of the results of the randomised, placebo-controlled, double-blind phase one trial on Monday.